Global Home Diagnostics Markets, Strategies, Trends & Forecast Report 2022-2027: Privacy Anonymity, Internet Effect, Rapid Result, Wellness Movement, & COVID-19 Impact Driving Growth

20 Jun 2022
www.prnewswire.com
Acquisition
DUBLIN, June 20, 2022 /PRNewswire/ -- The "Home Diagnostics Markets. Strategies and Trends. Forecasts by Application by Channel by Technology and by Country. With Market Analysis and Executive Guides. " report has been added to
ResearchAndMarkets.com's offering.
Covid-19 awakens the sleeping giant of at-home diagnostics. Home Diagnostics are set to help solve the pandemic problem. New technologies create rapid test solutions for the home market. Self-Sampling technology key.
Genetic DTC testing led the way. Now diagnostic testing is moving directly to the consumer. New sampling technology, rapid and multiplex tests have changed the picture on how and where testing is done. And the COVID-19 situation will lead the charge. This report explores the outlook for all manner of At Home Diagnostics. Find out where the action is and learn about the players.
Exciting technical developments especially in the seesaw between PCR and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even CRISPR diagnostics are now coming into play.
The report has hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing. The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
The report includes five-year market forecasts.
Make investment decisions and valuations with confidence using the latest data.
Home Diagnostics Recent Developments
Startup Detect Roll Next-Gen Molecular Instrument
Diagnostics of the Real World Third-Generation Platform
Labcorp Partnering With Getlabs Home Collection
Salignostics Closes Funding Round
Health Targets Market 2022
Grip Molecular Developing Home Respiratory Panel
Mainz Biomed Developing Home ColoAlert Assay
Fertility Closes Series A Financing Round
Continued Demand SARS-CoV-2 Rapid Tests
Rapid Covid-19 Test Results Risk Going Uncounted
Grants EUAs Direct-to-Consumer Coronavirus
Researchers Develop 15-Minute System
Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test
Lucira Health Files $115M
Spectrum Solutions Gets Mark Saliva Collection Devices
Sherlock Biosciences Receives Gates Foundation Grant COVID-19 Self-Test
LabCorp Receives for COVID-19 Test Home Collection
FemtoDx Launches Rapid At-Home Test Development COVID-19
approves first at-home coronavirus test
Free Home Tests Detect More Infections
Biohacking trend supports self testing
PerkinElmer EverlyWell Expand U.S. At-Home Health Test Market
Mylan, Atomo Diagnostics WHO Prequalification Approval HIV Self-Test
OraSure Technologies, Inc. Announces Acquisitions
Nigerian Govt Approves Alere Self-Test
Boots launches test treat service across branches
Scanwell Health moves beyond home testing
Healthy.io raises million at-home urinalysis tests
LetsGetChecked collects $30M more at-home health testing
TestCard, a Urine Test Read Smartphone
Digital Health Startup EverlyWell Raises $50M
Thriva adds test-at-home kits for female hormone cortisol stress
Tasso scores $6.1M patch-based home blood testing
Systems HEMAXIS receives CE/IVD mark
Abbott HbA1c point-of-care test reliably diagnoses diabetes
Industry Overview
Supplier
Independent specialized/esoteric
Independent national/regional
Independent analytical
Public National/regional
Hospital
Physician
Pharmacies
Audit body
Diagnostic Market Segments
Traditional Market Segmentation
Segmenting Home Diagnostics Market
Industry Structure
Hospital Testing Share
Economies Scale
Physician Office Lab's
Problem with POLS
Physician's Home Diagnostics
Diagnostic Plight Pharmacies - Trying good
Theranos Legacy
Market Trends
Factors Driving Growth
Privacy Anonymity
Internet Effect
Wellness Movement
COVID-19 Impact
Wellness Hurts
Economic Growth improves Living Standards
Diagnostic Technology Development
Multiplex Paradigm Shift
vs. Lateral Flow
Unusual Role
Self Send Competition
Relationship TeleHealth
Sample Collection - Knew?
Profiles Home Diagnostics Companies
1DropDiagnostics
Ador Diagnostics
Biotech
Applied BioCode
Diagnostics
Becton, Dickinson Company
Biocartis
BioFire Diagnostics (bioMerieux)
Cepheid (Danaher)
Health
Curetis N.V./Curetis GmbH
Systems
Detect
Diagenode Diagnostics
Everywell
Getlabs
Hologic
Invetech
Mesa Biotech (Thermo Fisher)
Fertility
Mobidiag (Hologic)
Panagene
Primerdesign (Novacyt)
Prominex
Qiagen
Roche Molecular Diagnostics
Salignostics
Scanwell Health
Seegene
Thriva
For more information about this report visit https://www.researchandmarkets.com/r/q3cvo3
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.